Acute Cardiovascular Care Association position statement for
the diagnosis and treatment of patients with acute myocardial
infarction complicated by cardiogenic shock: A document of the
Acute Cardiovascular Care Association of the European Society
of Cardiology

J 2020

Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology

ZEYMER, U., H. BUENO, C. B. GRANGER, J. HOCHMAN, K. HUBER et. al.

Basic information

Original name

Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology

Authors

ZEYMER, U., H. BUENO, C. B. GRANGER, J. HOCHMAN, K. HUBER, M. LETTINO, S. PRICE, F. SCHIELE, M. TUBARO, P. VRANCKX, D. ZAHGER and H. THIELE

Edition

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, LONDON, SAGE PUBLICATIONS LTD, 2020, 2048-8726

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30230 Other clinical medicine subjects

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

DAPT-SHOCK AMI

Impact factor

Impact factor: 4.696

RIV identification code

RIV/00216224:14110/20:00123182

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1177/2048872619894254

UT WoS

000517721200001

Keywords (in Czech)

DAPT-SHOCK AMI; Acute myocardial infarction; Cardiogenic shock; Revascularuzation therapies; mechanical circulatory support

Keywords in English

DAPT-SHOCK AMI; Acute myocardial infarction; Cardiogenic shock; Revascularuzation therapies; mechanical circulatory support

Abstract

V originále

(Dual Antiplatelet Therapy for Shock patients with Acute Myocardial Infarction (DAPT-SHOCK-AMI) trial; ClinicalTrials.gov: NCT03551964). Most of the guideline-recommended treatment strategies for patients with acute coronary syndromes have been tested in large randomised clinical trials. Still, a major challenge is represented by patients with acute myocardial infarction admitted with impending or established cardiogenic shock. Despite early revascularization the mortality of cardiogenic shock remains high and roughly half of patients do not survive until hospital discharge or 30-day follow-up. However, there is only limited evidence-based scientific knowledge in the cardiogenic shock setting. Therefore, recommendations and actual treatments are often based on retrospective or prospective registry data and extrapolations from randomised clinical trials in acute myocardial infarction patients without cardiogenic shock. This position statement will summarise the current consensus of the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock based on current evidence and will provide advice for clinical practice.

Links

90128, large research infrastructures

Name: CZECRIN III

Citovat

ZEYMER, U., H. BUENO, C. B. GRANGER, J. HOCHMAN, K. HUBER, M. LETTINO, S. PRICE, F. SCHIELE, M. TUBARO, P. VRANCKX, D. ZAHGER and H. THIELE. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology (Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Car). EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE. LONDON: SAGE PUBLICATIONS LTD, 2020, vol. 9, No 2, p. 183-197. ISSN 2048-8726. Available from: https://dx.doi.org/10.1177/2048872619894254.

@article{1808360,
   author = {Zeymer, U. and Bueno, H. and Granger, C. B. and Hochman, J. and Huber, K. and Lettino, M. and Price, S. and Schiele, F. and Tubaro, M. and Vranckx, P. and Zahger, D. and Thiele, H.},
   article_location = {LONDON},
   article_number = {2},
   doi = {http://dx.doi.org/10.1177/2048872619894254},
   keywords = {DAPT-SHOCK AMI; Acute myocardial infarction; Cardiogenic shock; Revascularuzation therapies; mechanical circulatory support},
   language = {eng},
   issn = {2048-8726},
   journal = {EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE},
   note = {DAPT SHOCK AMI (Prague - 23)},
   title = {Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology},
   url = {https://academic.oup.com/ehjacc/article/9/2/183/5933392},
   volume = {9},
   year = {2020}
}

TY  - JOUR
ID  - 1808360
AU  - Zeymer, U. - Bueno, H. - Granger, C. B. - Hochman, J. - Huber, K. - Lettino, M. - Price, S. - Schiele, F. - Tubaro, M. - Vranckx, P. - Zahger, D. - Thiele, H.
PY  - 2020
TI  - Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology
JF  - EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE
VL  - 9
IS  - 2
SP  - 183-197
EP  - 183-197
PB  - SAGE PUBLICATIONS LTD
SN  - 20488726
N1  - DAPT SHOCK AMI (Prague - 23)
KW  - DAPT-SHOCK AMI
KW  - Acute myocardial infarction
KW  - Cardiogenic shock
KW  - Revascularuzation therapies
KW  - mechanical circulatory support
UR  - https://academic.oup.com/ehjacc/article/9/2/183/5933392
N2  - (Dual Antiplatelet Therapy for Shock patients with Acute Myocardial Infarction (DAPT-SHOCK-AMI) trial; ClinicalTrials.gov: NCT03551964). Most of the guideline-recommended treatment strategies for patients with acute coronary syndromes have been tested in large randomised clinical trials. Still, a major challenge is represented by patients with acute myocardial infarction admitted with impending or established cardiogenic shock. Despite early revascularization the mortality of cardiogenic shock remains high and roughly half of patients do not survive until hospital discharge or 30-day follow-up. However, there is only limited evidence-based scientific knowledge in the cardiogenic shock setting. Therefore, recommendations and actual treatments are often based on retrospective or prospective registry data and extrapolations from randomised clinical trials in acute myocardial infarction patients without cardiogenic shock. This position statement will summarise the current consensus of the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock based on current evidence and will provide advice for clinical practice.
ER  -

ZEYMER, U., H. BUENO, C. B. GRANGER, J. HOCHMAN, K. HUBER, M. LETTINO, S. PRICE, F. SCHIELE, M. TUBARO, P. VRANCKX, D. ZAHGER and H. THIELE. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology (Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Car). \textit{EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE}. LONDON: SAGE PUBLICATIONS LTD, 2020, vol.~9, No~2, p.~183-197. ISSN~2048-8726. Available from: https://dx.doi.org/10.1177/2048872619894254.

Detailed Information on Publication Record